Profil
Eric Olson is Chief Business Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc. since 2025.
Formerly, Mr. Olson was Chief Business Officer at Stoke Therapeutics, Inc. and Vice President & Head-Business Development at Alnylam Pharmaceuticals, Inc. Education includes undergraduate studies at Connecticut College, graduate studies at New York University, and an MBA from the University of Virginia Darden School of Business.
Aktiva positioner av Eric Olson
| Företag | Position | Start |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Företagsledare/Principal | 2025-09-22 |
Tidigare kända positioner av Eric Olson
| Företag | Position | Slut |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Företagsledare/Principal | - |
| STOKE THERAPEUTICS, INC. | Företagsledare/Principal | - |
Eric Olsons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Ultragenyx Pharmaceutical, Inc.
Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Connecticut College
Connecticut College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Virginia Darden School of Business
University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
















